Digestive issues such as nausea, vomiting, diarrhea, and constipation are some of the main aftereffects to be expected
Used needles become dull, develop microscopic barbs on the tip, and require more force to penetrate tissue
GLP-1 receptor agonists like semaglutide and tirzepatide work by mimicking a naturally occurring hormone involved in appetite regulation and blood sugar management
PlexusDx compounded semaglutide injections, oral semaglutide, tirzepatide injections, and oral tirzepatide all meet this standard because they contain active pharmaceutical ingredients identical to FDA-approved GLP-1 and GIP receptor agonists
Most patients follow a maintenance phase once they reach an effective therapeutic dose, typically between 5 mg and 15 mg weekly for injectable tirzepatide